SOTIO partners with Biocytogen to expand ADC oncology pipeline
SOTIO will pay up to $325.5m in upfront and milestone payments for developing multiple bispecific antibody-drug conjugates (ADCs).
Immuno
Impact and implications of the $35 monthly price cap on asthma inhalers
Anti-obesity drugs will be 2024’s defining trend
ASCO24: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Pheon cashes in on ADC trend and raises $120m in Series B
Novo Holdings-backed Commit launches with $17.2m in seed funding
Ultimovacs downsizes to funnel funds to cancer vaccine programme
Century secures $60m in stock sale and buys preclinical cell therapy biotech
